Hoth Therapeutics, Inc. (HOTH)

USD 0.83

(3.03%)

Annual Income Statements

(In USD)
Breakdown 2023 2022 2021 2020 2019 2018
Revenue - - - - - -
Cost of Revenue - 66.83 Thousand 46.87 Million 25.87 Thousand 31.62 Thousand 28.25 Thousand
Gross Profit - -66.83 Thousand -46.87 Million -25.87 Thousand -31.62 Thousand -28.25 Thousand
Operating Expenses 7.69 Million 11.06 Million 14.1 Million 7.3 Million 7.71 Million 2.49 Million
Selling, General and Administrative Expenses 4.21 Million 6.13 Million 6.57 Million 3.95 Million 5.05 Million 1.22 Million
Research and Development Expenses 3.48 Million 4.93 Million 7.52 Million 2.88 Million 2.12 Million 1.01 Million
Other Expenses - 451.14 Thousand -212.26 Thousand 454.2 Thousand 538.57 Thousand 258.71 Thousand
Cost and Expenses 7.69 Million 11.06 Million 14.1 Million 7.3 Million 7.71 Million 2.49 Million
Operating Income -7.69 Million -11.06 Million -14.1 Million -7.3 Million -7.71 Million -2.49 Million
Interest Expense - 305.4 Thousand - - - -
Income Tax Expense - 305.4 Thousand -1.04 -205.25 Thousand -10.36 Thousand -159.91 Thousand
Earnings before Tax -7.84 Million -11.37 Million -14.31 Million -7.19 Million -7.7 Million -2.49 Million
Net Income -7.84 Million -11.67 Million -14.31 Million -7.19 Million -7.69 Million -2.49 Million
Earnings Per Share Basic -2.30 -9.75 -16.03 -14.56 -20.99 -6.62
Earnings Per Share Diluted -2.30 -9.75 -16.03 -14.56 -20.99 -6.62
Weighted Average Shares Outstanding 3.4 Million 1.19 Million 893.2 Thousand 494.51 Thousand 366.58 Thousand 376.98 Thousand
Weighted Average Shares Outstanding (Diluted) 3.4 Million 1.19 Million 893.2 Thousand 494.51 Thousand 366.58 Thousand 376.98 Thousand
Gross Margin - - - - - -
EBIT Margin - - - - - -
Profit Margin - - - - - -
EBITDA -153.14 Thousand - -14.1 Million -7.3 Million -7.71 Million -2.49 Million
Earnings Before Tax Margin - - - - - -

Income Statement Charts